BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1301 related articles for article (PubMed ID: 25410383)

  • 21. Histone Deacetylase Inhibitors as Anticancer Drugs.
    Eckschlager T; Plch J; Stiborova M; Hrabeta J
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28671573
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and Therapeutic Implications of Histone Epigenetic Modulators in Breast Cancer.
    Walsh L; Gallagher WM; O'Connor DP; Ní Chonghaile T
    Expert Rev Mol Diagn; 2016; 16(5):541-51. PubMed ID: 26895288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetics and cancer treatment.
    Kristensen LS; Nielsen HM; Hansen LL
    Eur J Pharmacol; 2009 Dec; 625(1-3):131-42. PubMed ID: 19836388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harnessing Epigenetics for Breast Cancer Therapy: The Role of DNA Methylation, Histone Modifications, and MicroRNA.
    Szczepanek J; Skorupa M; Jarkiewicz-Tretyn J; Cybulski C; Tretyn A
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New Promises to Cure Cancer and Other Genetic Diseases/Disorders: Epi-drugs Through Epigenetics.
    Duan YT; Sangani CB; Liu W; Soni KV; Yao Y
    Curr Top Med Chem; 2019; 19(12):972-994. PubMed ID: 31161992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic cancer therapy: Proof of concept and remaining challenges.
    Mund C; Lyko F
    Bioessays; 2010 Nov; 32(11):949-57. PubMed ID: 21154865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigenetic regulation of gene expression as an anticancer drug target.
    Ferguson LR; Tatham AL; Lin Z; Denny WA
    Curr Cancer Drug Targets; 2011 Feb; 11(2):199-212. PubMed ID: 21158714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epi-drugs as triple-negative breast cancer treatment.
    Idrissou M; Sanchez A; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
    Epigenomics; 2020 Apr; 12(8):725-742. PubMed ID: 32396394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetics and oncology.
    Mummaneni P; Shord SS
    Pharmacotherapy; 2014 May; 34(5):495-505. PubMed ID: 24619798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epigenetic transitions: towards therapeutic targets.
    Kalebic T
    Expert Opin Ther Targets; 2003 Dec; 7(6):693-9. PubMed ID: 14640906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenomes as therapeutic targets.
    Hamm CA; Costa FF
    Pharmacol Ther; 2015 Jul; 151():72-86. PubMed ID: 25797698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
    Valdespino-Gómez VM; Valdespino-Castillo VE
    Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic mechanisms in AML - a target for therapy.
    Oki Y; Issa JP
    Cancer Treat Res; 2010; 145():19-40. PubMed ID: 20306243
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy.
    Lu Y; Chan YT; Tan HY; Li S; Wang N; Feng Y
    Mol Cancer; 2020 Apr; 19(1):79. PubMed ID: 32340605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Histone modification therapy of cancer.
    Biancotto C; Frigè G; Minucci S
    Adv Genet; 2010; 70():341-86. PubMed ID: 20920755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic targeting in pancreatic cancer.
    van Kampen JG; Marijnissen-van Zanten MA; Simmer F; van der Graaf WT; Ligtenberg MJ; Nagtegaal ID
    Cancer Treat Rev; 2014 Jun; 40(5):656-64. PubMed ID: 24433955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting the histone orthography of cancer: drugs for writers, erasers and readers.
    Simó-Riudalbas L; Esteller M
    Br J Pharmacol; 2015 Jun; 172(11):2716-32. PubMed ID: 25039449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.
    Biswas S; Rao CM
    Eur J Pharmacol; 2018 Oct; 837():8-24. PubMed ID: 30125562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigenetic therapies in patients with solid tumors: Focus on monotherapy with deoxyribonucleic acid methyltransferase inhibitors and histone deacetylase inhibitors.
    Katarzyna R; Lucyna B
    J Cancer Res Ther; 2019; 15(5):961-970. PubMed ID: 31603095
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic drugs take on cancer.
    Kaiser J
    Science; 2010 Oct; 330(6004):576-8. PubMed ID: 21030620
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 66.